Clinical Trial Update: Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating mepolizumab for chronic cough associated with eosinophilic airway diseases has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Cough
• Eosinophilic Bronchitis

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: McMaster University | Conditions: Chronic Cough, Eosinophilic Bronchitis | Phase 4 | Status: COMPLETED | Results posted: 2025-09-16